Matches in Nanopublications for { ?s ?p "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- NP637387.RAb5GbrSUQUgOuDiC1tjL_J2zAQtVoyoFlqXBM-yfaXLI130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637387.RAb5GbrSUQUgOuDiC1tjL_J2zAQtVoyoFlqXBM-yfaXLI130_provenance.
- NP637934.RAfF5a2fQzQKe1N5LY9KmTG3rOvdWJJBzZsyq4ZD9CuUc130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP637934.RAfF5a2fQzQKe1N5LY9KmTG3rOvdWJJBzZsyq4ZD9CuUc130_provenance.
- assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP1102773.RAcnfUNPnqOM89WWkJ-kVvSEU1HegbFFdEHO8uQJMW75M130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1102773.RAcnfUNPnqOM89WWkJ-kVvSEU1HegbFFdEHO8uQJMW75M130_provenance.
- NP1102774.RAW1gXN0uLZn1hWzR3AvaNYsGFFERcOdd9Z_nqZ8JD8Dg130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1102774.RAW1gXN0uLZn1hWzR3AvaNYsGFFERcOdd9Z_nqZ8JD8Dg130_provenance.
- NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985068.RALTOcLpmHkgBegCHEMPuKfeTaHuanY6izSvQX-k-yMqM130_provenance.
- NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP985070.RAFCRL_O_VuDItopb2S_vzYO04alE4oZSp5hkykuRl-7I130_provenance.
- NP1102772.RAH_wAops4U-lHFkjIAEQ9sYdN2K4GGSbdX7WvEe78h_A130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1102772.RAH_wAops4U-lHFkjIAEQ9sYdN2K4GGSbdX7WvEe78h_A130_provenance.
- NP1102771.RAyZ--smBu8KuJSHVG97gQsb8sOgSTgyAHd_QHUhYii6o130_assertion description "[We developed three new cell lines from HER2 gene-amplified gastric cancer cell lines (GLM-1, GLM-4, NCI N-87) by a new in vivo selection method consisting of the repeated culture of small residual peritoneal metastasis but not subcutaneous tumor after Tmab treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1102771.RAyZ--smBu8KuJSHVG97gQsb8sOgSTgyAHd_QHUhYii6o130_provenance.